ArticleJournal of enzyme inhibition and medicinal chemistry2017

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors.

Adriano Mollica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.